Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuromuscular Diseases | 2 | 2022 | 54 | 1.340 |
Why?
|
| Diabetic Neuropathies | 7 | 2021 | 58 | 1.270 |
Why?
|
| Neural Conduction | 3 | 2020 | 92 | 0.770 |
Why?
|
| Patient Preference | 1 | 2022 | 103 | 0.750 |
Why?
|
| Neuralgia | 2 | 2021 | 44 | 0.740 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2020 | 4 | 0.710 |
Why?
|
| Placebo Effect | 2 | 2017 | 24 | 0.590 |
Why?
|
| Myositis, Inclusion Body | 3 | 2023 | 8 | 0.580 |
Why?
|
| Drinking | 1 | 2017 | 34 | 0.560 |
Why?
|
| Distal Myopathies | 1 | 2016 | 1 | 0.550 |
Why?
|
| Deglutition | 1 | 2017 | 47 | 0.540 |
Why?
|
| Telemedicine | 1 | 2022 | 421 | 0.530 |
Why?
|
| Genetic Testing | 1 | 2022 | 995 | 0.520 |
Why?
|
| Fatigue | 1 | 2017 | 218 | 0.510 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2017 | 107 | 0.510 |
Why?
|
| Receptors, Virus | 1 | 2014 | 104 | 0.450 |
Why?
|
| Retinitis Pigmentosa | 1 | 2014 | 84 | 0.430 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 176 | 0.420 |
Why?
|
| DNA Mutational Analysis | 4 | 2014 | 796 | 0.420 |
Why?
|
| Ataxia | 1 | 2014 | 168 | 0.410 |
Why?
|
| Quinidine | 1 | 2012 | 9 | 0.400 |
Why?
|
| Dextromethorphan | 1 | 2012 | 11 | 0.400 |
Why?
|
| Acetamides | 2 | 2009 | 49 | 0.390 |
Why?
|
| Ribonucleotide Reductases | 1 | 2009 | 10 | 0.340 |
Why?
|
| Double-Blind Method | 9 | 2023 | 1573 | 0.330 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2009 | 27 | 0.330 |
Why?
|
| Gastrointestinal Motility | 1 | 2009 | 45 | 0.330 |
Why?
|
| Thymectomy | 2 | 2020 | 19 | 0.320 |
Why?
|
| Pain | 2 | 2009 | 448 | 0.310 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2009 | 68 | 0.310 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 211 | 0.300 |
Why?
|
| Myasthenia Gravis | 2 | 2020 | 71 | 0.300 |
Why?
|
| Prednisone | 2 | 2020 | 273 | 0.300 |
Why?
|
| Gastrointestinal Diseases | 2 | 2009 | 336 | 0.270 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 501 | 0.260 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 658 | 0.240 |
Why?
|
| Middle Aged | 14 | 2021 | 25798 | 0.240 |
Why?
|
| Adult | 13 | 2023 | 28926 | 0.220 |
Why?
|
| Mutation | 3 | 2014 | 5794 | 0.220 |
Why?
|
| Humans | 24 | 2023 | 122853 | 0.200 |
Why?
|
| Male | 18 | 2023 | 59866 | 0.200 |
Why?
|
| Dystrophin | 1 | 2021 | 37 | 0.190 |
Why?
|
| Muscle, Skeletal | 3 | 2021 | 932 | 0.190 |
Why?
|
| Aged | 10 | 2021 | 18917 | 0.190 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 30 | 0.180 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 99 | 0.180 |
Why?
|
| Female | 19 | 2023 | 65278 | 0.180 |
Why?
|
| Muscle Contraction | 1 | 2021 | 186 | 0.180 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2021 | 63 | 0.180 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2010 | 14 | 0.170 |
Why?
|
| Treatment Outcome | 9 | 2021 | 12070 | 0.170 |
Why?
|
| Lipid Metabolism, Inborn Errors | 2 | 2010 | 19 | 0.170 |
Why?
|
| Plasmids | 1 | 2021 | 516 | 0.170 |
Why?
|
| Communication | 1 | 2022 | 508 | 0.150 |
Why?
|
| Pain Measurement | 4 | 2021 | 330 | 0.140 |
Why?
|
| Myoclonus | 1 | 1997 | 32 | 0.140 |
Why?
|
| Placebos | 2 | 2021 | 239 | 0.140 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2017 | 58 | 0.140 |
Why?
|
| Genetic Therapy | 1 | 2021 | 706 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 646 | 0.130 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1997 | 129 | 0.130 |
Why?
|
| Spiro Compounds | 1 | 2015 | 13 | 0.130 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 1997 | 199 | 0.130 |
Why?
|
| Polyneuropathies | 1 | 2015 | 24 | 0.130 |
Why?
|
| Pyrazines | 1 | 2015 | 74 | 0.130 |
Why?
|
| Psychometrics | 1 | 2018 | 666 | 0.120 |
Why?
|
| Catheter Ablation | 1 | 2017 | 233 | 0.110 |
Why?
|
| Heart Rate | 1 | 2017 | 584 | 0.110 |
Why?
|
| Action Potentials | 1 | 2017 | 499 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2016 | 379 | 0.110 |
Why?
|
| Family Health | 1 | 2014 | 258 | 0.110 |
Why?
|
| Electrocardiography | 2 | 2017 | 964 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 2827 | 0.100 |
Why?
|
| Quality of Life | 3 | 2018 | 1918 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 3641 | 0.100 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 80 | 0.100 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2012 | 96 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2012 | 82 | 0.090 |
Why?
|
| Muscular Atrophy | 1 | 2012 | 75 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2012 | 267 | 0.090 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 101 | 0.090 |
Why?
|
| Biopsy | 2 | 2009 | 1256 | 0.090 |
Why?
|
| Rhabdomyolysis | 1 | 2010 | 35 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 6325 | 0.090 |
Why?
|
| Cataract | 1 | 2012 | 218 | 0.080 |
Why?
|
| Basal Ganglia | 1 | 2009 | 54 | 0.080 |
Why?
|
| RNA, Transfer | 1 | 2009 | 70 | 0.080 |
Why?
|
| Ovary | 1 | 2012 | 390 | 0.080 |
Why?
|
| Analgesics | 2 | 2007 | 129 | 0.080 |
Why?
|
| Neurologic Examination | 1 | 2009 | 196 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 423 | 0.080 |
Why?
|
| Single-Blind Method | 2 | 2020 | 233 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 574 | 0.070 |
Why?
|
| Carbamazepine | 1 | 2006 | 49 | 0.070 |
Why?
|
| Animals | 4 | 2023 | 33923 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1598 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 503 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 1246 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2017 | 4524 | 0.060 |
Why?
|
| Disease Progression | 2 | 2023 | 1996 | 0.060 |
Why?
|
| Young Adult | 5 | 2020 | 8826 | 0.050 |
Why?
|
| Isometric Contraction | 1 | 2021 | 20 | 0.050 |
Why?
|
| Walk Test | 1 | 2021 | 23 | 0.050 |
Why?
|
| Time | 1 | 2021 | 92 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2021 | 193 | 0.040 |
Why?
|
| Thymoma | 1 | 2020 | 11 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2021 | 72 | 0.040 |
Why?
|
| Thymus Neoplasms | 1 | 2020 | 29 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2021 | 106 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2020 | 141 | 0.040 |
Why?
|
| Carnitine | 2 | 2010 | 78 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1378 | 0.040 |
Why?
|
| Time Factors | 1 | 2009 | 6202 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 3479 | 0.040 |
Why?
|
| Brain | 1 | 2009 | 2961 | 0.040 |
Why?
|
| Sural Nerve | 1 | 1997 | 47 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1997 | 91 | 0.040 |
Why?
|
| Toes | 1 | 1997 | 26 | 0.040 |
Why?
|
| Canada | 1 | 2018 | 294 | 0.040 |
Why?
|
| Pressure | 1 | 1997 | 130 | 0.040 |
Why?
|
| United States | 2 | 2023 | 10538 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 2443 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3665 | 0.030 |
Why?
|
| DNA Polymerase gamma | 1 | 2012 | 10 | 0.030 |
Why?
|
| Glutarates | 1 | 2012 | 27 | 0.030 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 28 | 0.020 |
Why?
|
| DNA | 1 | 1997 | 1608 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2814 | 0.020 |
Why?
|
| Term Birth | 1 | 2010 | 32 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4308 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 19037 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 581 | 0.020 |
Why?
|
| Succinate Dehydrogenase | 1 | 2009 | 7 | 0.020 |
Why?
|
| Triazines | 1 | 2009 | 29 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 113 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1069 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1731 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2010 | 340 | 0.020 |
Why?
|
| Drug Eruptions | 1 | 2007 | 33 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 17647 | 0.020 |
Why?
|
| Dizziness | 1 | 2006 | 27 | 0.020 |
Why?
|
| Headache | 1 | 2007 | 107 | 0.020 |
Why?
|
| Nausea | 1 | 2006 | 98 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2006 | 372 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2006 | 465 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1689 | 0.010 |
Why?
|
| Heart | 1 | 2007 | 725 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 15927 | 0.010 |
Why?
|
| Pregnancy | 1 | 2010 | 7126 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2010 | 8120 | 0.010 |
Why?
|